FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1888578735> ?p ?o ?g. }

• W1888578735 endingPage "26769" @default.
• W1888578735 startingPage "26757" @default.
• W1888578735 abstract "Therapies for treatment of patients with primary sclerosing cholangitis (PSC) include administration of ursodeoxycholic acid (UDCA) alone, or combination with metronidazole (MTZ) or mycophenolate mofetil (MMF), respectively. However, the optimum regimen still remains inconclusive. We aimed to compare interventions in terms of patient mortality or liver transplantation (MOLT), progression of liver histological stage (POLHS), serum bilirubin, alkaline phosphatase (ALP) levels and adverse events (AE).We searched PubMed, Embase and the Cochrane Library for randomized controlled trials until 31, Jan 2015. We estimated hazard ratios (HRs), odds ratios (ORs) and mean difference (MD) between treatments on clinical outcomes. Sensitivity analyses based on the dose of UDCA, quality of trials or treatment duration were also performed.Ten RCTs were included. Compared with UDCA plus MTZ, UDCA (HR 0.28, 95%CI 0.01-3.41), UDCA plus MMF (HR 0.08, 95%CI 0.00-4.18), or OBS (HR 0.28, 95%CI 0.01-3.98) all provided an increased risk of MOLT. UDCA provided a significant reduction in bilirubin and ALP levels compared with OBS (MD -13.92, P < 0.001; MD -484.34, P < 0.001; respectively). With respect to POLHS, although differing not significantly, UDCA plus MTZ had a tendency to improve LHS more than UDCA (OR 1.33), UDCA plus MMF (OR 3.24) or OBS (OR 1.08). Additionally, UDCA plus MTZ (MD -544.66, P < 0.001) showed a significant reduction in ALP levels compared with OBS, but appeared to be associated with more AEs compared with UDCA (OR 5.09), UDCA plus MMF (OR 4.80) or OBS (OR 7.21).MTZ plus UDCA was the most effective therapy in survival rates and liver histological progression." @default.
• W1888578735 created "2016-06-24" @default.
• W1888578735 creator A5010058636 @default.
• W1888578735 creator A5012938699 @default.
• W1888578735 creator A5030038857 @default.
• W1888578735 creator A5038875913 @default.
• W1888578735 creator A5040253604 @default.
• W1888578735 creator A5065945481 @default.
• W1888578735 creator A5068624665 @default.
• W1888578735 creator A5079375772 @default.
• W1888578735 creator A5086503266 @default.
• W1888578735 date "2015-09-10" @default.
• W1888578735 modified "2023-10-18" @default.
• W1888578735 title "A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis" @default.
• W1888578735 cites W139139452 @default.
• W1888578735 cites W1566103919 @default.
• W1888578735 cites W1617200419 @default.
• W1888578735 cites W16640574 @default.
• W1888578735 cites W1717103253 @default.
• W1888578735 cites W1851143213 @default.
• W1888578735 cites W1909502687 @default.
• W1888578735 cites W1968221120 @default.
• W1888578735 cites W1970023010 @default.
• W1888578735 cites W1971724429 @default.
• W1888578735 cites W1982014243 @default.
• W1888578735 cites W1982878892 @default.
• W1888578735 cites W1992447918 @default.
• W1888578735 cites W1993535010 @default.
• W1888578735 cites W2004909975 @default.
• W1888578735 cites W2005901103 @default.
• W1888578735 cites W2007872832 @default.
• W1888578735 cites W2016020580 @default.
• W1888578735 cites W2019796203 @default.
• W1888578735 cites W2030752472 @default.
• W1888578735 cites W2040741828 @default.
• W1888578735 cites W2044865546 @default.
• W1888578735 cites W2053629542 @default.
• W1888578735 cites W2056089146 @default.
• W1888578735 cites W2056271161 @default.
• W1888578735 cites W2061397044 @default.
• W1888578735 cites W2063331289 @default.
• W1888578735 cites W2065130512 @default.
• W1888578735 cites W2070826820 @default.
• W1888578735 cites W2082789659 @default.
• W1888578735 cites W2094166732 @default.
• W1888578735 cites W2097149703 @default.
• W1888578735 cites W2098923148 @default.
• W1888578735 cites W2099482902 @default.
• W1888578735 cites W2102619353 @default.
• W1888578735 cites W2107039790 @default.
• W1888578735 cites W2114097867 @default.
• W1888578735 cites W2118002846 @default.
• W1888578735 cites W2124194529 @default.
• W1888578735 cites W2133403920 @default.
• W1888578735 cites W2140699272 @default.
• W1888578735 cites W2147964067 @default.
• W1888578735 cites W2150529573 @default.
• W1888578735 cites W2317726708 @default.
• W1888578735 cites W2335484642 @default.
• W1888578735 cites W2588681363 @default.
• W1888578735 cites W3140593116 @default.
• W1888578735 cites W4210406669 @default.
• W1888578735 cites W4237645899 @default.
• W1888578735 cites W72094521 @default.
• W1888578735 doi "https://doi.org/10.18632/oncotarget.5610" @default.
• W1888578735 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4694950" @default.
• W1888578735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26378046" @default.
• W1888578735 hasPublicationYear "2015" @default.
• W1888578735 type Work @default.
• W1888578735 sameAs 1888578735 @default.
• W1888578735 citedByCount "21" @default.
• W1888578735 countsByYear W18885787352016 @default.
• W1888578735 countsByYear W18885787352017 @default.
• W1888578735 countsByYear W18885787352018 @default.
• W1888578735 countsByYear W18885787352019 @default.
• W1888578735 countsByYear W18885787352020 @default.
• W1888578735 countsByYear W18885787352021 @default.
• W1888578735 countsByYear W18885787352022 @default.
• W1888578735 countsByYear W18885787352023 @default.
• W1888578735 crossrefType "journal-article" @default.
• W1888578735 hasAuthorship W1888578735A5010058636 @default.
• W1888578735 hasAuthorship W1888578735A5012938699 @default.
• W1888578735 hasAuthorship W1888578735A5030038857 @default.
• W1888578735 hasAuthorship W1888578735A5038875913 @default.
• W1888578735 hasAuthorship W1888578735A5040253604 @default.
• W1888578735 hasAuthorship W1888578735A5065945481 @default.
• W1888578735 hasAuthorship W1888578735A5068624665 @default.
• W1888578735 hasAuthorship W1888578735A5079375772 @default.
• W1888578735 hasAuthorship W1888578735A5086503266 @default.
• W1888578735 hasBestOaLocation W18885787351 @default.
• W1888578735 hasConcept C126322002 @default.
• W1888578735 hasConcept C156957248 @default.
• W1888578735 hasConcept C160160445 @default.
• W1888578735 hasConcept C168563851 @default.
• W1888578735 hasConcept C181199279 @default.
• W1888578735 hasConcept C185592680 @default.
• W1888578735 hasConcept C197934379 @default.
• W1888578735 hasConcept C207103383 @default.

• next